Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

Amgen (AMGN) stock spiked after the company ruled out out bone density concerns linked to obesity drug MariTide, following a ...

The magnitude of the stock drop on such scant evidence gives an indication of the importance investors are placing on ...

Critics quickly noticed another speed readout on the passenger side of the car, which was left unblurred, drawing further ire ...

Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...

The news led to a stock surge on expectations that forthcoming data for the company’s experimental gene therapy for Rett ...

The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...

The creators of Halide developed the app. It includes the polished design and in-depth controls you'd expect from the company ...

US deputy secretary of state Kurt Campbell will participate this week in the first India-US Indian Ocean Dialogue in New ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...